Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice

被引:0
|
作者
Yunsik Choi
Sanghyuk Lee
Kapyoul Kim
Soo-Hyun Kim
Yeun-Jun Chung
Charles Lee
机构
[1] Ewha Womans University,Department of Life Sciences
[2] The Catholic University of Korea,Department of Microbiology, Precision Medicine Research Center, IRCGP, College of Medicine
[3] The Jackson Laboratory for Genomic Medicine,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Cancer immunotherapy is a promising way to eliminate tumor cells by using the patient’s own immune system. Selecting the appropriate animal models to develop or validate preclinical immunotherapeutic trials is now an important aspect of many cancer research programs. Here we discuss the advantages and limitations of using genetically engineered immunodeficient mouse models, patient-derived xenografts (PDXs), and humanized mouse models for developing and testing immunotherapeutic strategies.
引用
收藏
页码:1 / 9
页数:8
相关论文
共 50 条
  • [11] Establishment of patient-derived cancer xenografts in immunodeficient NOG mice
    Chijiwa, Tsuyoshi
    Kawai, Kenji
    Noguchi, Akira
    Sato, Hidemitsu
    Hayashi, Akimune
    Cho, Haruhiko
    Shiozawa, Manabu
    Kishida, Takeshi
    Morinaga, Soichiro
    Yokose, Tomoyuki
    Katayama, Makoto
    Takenaka, Nobuo
    Suemizu, Hiroshi
    Yamada, Roppei
    Nakamura, Yoshiyasu
    Ohtsu, Takashi
    Takano, Yasuo
    Imai, Kohzoh
    Miyagi, Yohei
    Nakamura, Masato
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 47 (01) : 61 - 70
  • [12] Autologous humanized mouse models to study combination and single-agent immunotherapy for colorectal cancer patient-derived xenografts
    Kanikarla Marie, Preeti
    Sorokin, Alexey V.
    Bitner, Lea A.
    Aden, Rebecca
    Lam, Michael
    Manyam, Ganiraju
    Woods, Melanie N.
    Anderson, Amanda
    Capasso, Anna
    Fowlkes, Natalie
    Overman, Michael J.
    Menter, David G.
    Kopetz, Scott
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [13] Functional study of glioblastoma (GBM) intratumour genomic heterogeneity and evolution using patient-derived xenografts (PDXs)
    Chigancas, V.
    Gonzalez-Junca, A.
    Parra, J. L.
    Mayor, R.
    Seoane, J.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S1 - S1
  • [14] Histopathologic and immunophenotypic characterization of patient-derived pediatric malignant hepatocellular tumor xenografts (PDXs)
    Patel, Kalyani R.
    Espinoza, Andres F.
    Urbicain, Martin
    Patel, Roma H.
    Major, Angela
    Sarabia, Stephen F.
    Lopez-Terrada, Dolores
    Vasudevan, Sanjeev A.
    Woodfield, Sarah E.
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 255
  • [15] Preclinal models of patient-derived xenografts on humanized mice for translational immuno-oncology research
    Stecklum, M.
    Wulf-Goldenberg, A.
    Paterka, M.
    Brzezicha, B.
    Fichtner, I.
    Hoffmann, J.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E101 - E101
  • [16] The genetic makeup of patient-derived xenografts shapes the immune landscape of humanized mice tumors.
    Singh, Maneesh
    Bradshaw, Laura
    Prickett, Laura B.
    Matthew, Griffin
    San Martin, Maryann
    Monks, Noel
    Drew, Lisa
    Barry, Simon T.
    Reimer, Corinne
    Proia, Theresa
    CANCER RESEARCH, 2021, 81 (13)
  • [17] Genomic data analysis workflows for tumors from patient-derived xenografts (PDXs): Challenges and guidelines
    Woo, Xing Yi
    Srivastava, Anuj
    Graber, Joel H.
    Yadav, Vinod
    Sarsani, Vishal Kumar
    Simons, Al
    Beane, Glen
    Grubb, Stephen
    Ananda, Guruprasad
    Stafford, Grace
    Chuang, Jeffrey H.
    Airhart, Susan D.
    Karuturi, R. Krishna
    George, Joshy
    Bult, Carol J.
    CANCER RESEARCH, 2019, 79 (13)
  • [18] Patient Characteristics Associated with Growth of Patient-Derived Tumor Implants in Mice (Patient-Derived Xenografts)
    Guerrero, Tatiana Hernandez
    Banos, Natalia
    Nevado, Laura del Puerto
    Mahillo-Fernandez, Ignacio
    De-Speville, Bernard Doger
    Calvo, Emiliano
    Wick, Michael
    Garcia-Foncillas, Jesus
    Moreno, Victor
    CANCERS, 2023, 15 (22)
  • [19] Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells
    Hou, Xiaoying
    Du, Cong
    Lu, Ligong
    Yuan, Shengtao
    Zhan, Meixiao
    You, Pengtao
    Du, Hongzhi
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2022, 20 (01)
  • [20] Opportunities and challenges of patient-derived models in cancer research: patient-derived xenografts, patient-derived organoid and patient-derived cells
    Xiaoying Hou
    Cong Du
    Ligong Lu
    Shengtao Yuan
    Meixiao Zhan
    Pengtao You
    Hongzhi Du
    World Journal of Surgical Oncology, 20